Tela Bio Inc (TELA NASDAQ) stock market data APIs
$1.9567
0(0%)
as of July 1, 2025
Try our APIs with
free plan!
Tela Bio Inc Financial Data Overview
Price chart is built with
Anychart
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Prev. Close
1.9567
Open
1.9567
High
1.9817
Low
1.831
52 wk Range
0.8645-5.175
Market Cap
77 132 K
Shares Outstanding
39 555 K
Revenue
71 217 K
EPS
-0.25
Beta
0.786
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tela Bio Inc data using free add-ons & libraries
Get Tela Bio Inc Fundamental Data
Tela Bio Inc Fundamental data includes:
- Net Revenue: 71 217 K
- EBITDA: -38 716 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: -0.2075
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tela Bio Inc News
New
Deutsche Bank initiates coverage on Telekom Austria with “hold” rating
Investing.com -- Deutsche Bank has initiated coverage on Telekom Austria (VIE:TELA) with a "hold" rating and a price target of €11, citing the group’s steady performance across challenging markets...
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction s...
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, tod...
TELA Bio Appoints Jeffrey Blizard as President
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, t...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
